Hypermethylated genes as biomarkers of breast cancer

por Fackler, MJ, Stearns, V, Khan, SA, Sukumar, S
Publicado 2009

A phase 1 study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women awaiting mastectomy

por Stearns, V, Jacobs, L, Khouri, N, Jeter, S, Powers, P, Shahverdi, K, Brown, R, Rudek, M, Gabrielson, E, Zhang, Z, Tsangaris, T, Sukumar, S
Publicado 2009

Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case–control study

por Henry, N L, Pchejetski, D, A'Hern, R, Nguyen, A T, Charles, P, Waxman, J, Li, L, Storniolo, A M, Hayes, D F, Flockhart, D A, Stearns, V, Stebbing, J
Publicado 2010

Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy

por Henry, N L, Nguyen, A, Azzouz, F, Li, L, Robarge, J, Philips, S, Cao, D, Skaar, T C, Rae, J M, Storniolo, A M, Flockhart, D A, Hayes, D F, Stearns, V
Publicado 2010

Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects

por Henry, N L, Chan, H-P, Dantzer, J, Goswami, C P, Li, L, Skaar, T C, Rae, J M, Desta, Z, Khouri, N, Pinsky, R, Oesterreich, S, Zhou, C, Hadjiiski, L, Philips, S, Robarge, J, Nguyen, A T, Storniolo, A M, Flockhart, D A, Hayes, D F, Helvie, M A, Stearns, V
Publicado 2013